Influence of Therapeutic Education in Patients With Joint Inflammation Treated With a Biological Treatment

Impact of a Therapeutic Education Program in Patients With Non-radiological Spondyloarthritis Treated With Anti-tumor Necrosis Factor (TNF)

To describe, with a patient reported score (BIOSECURE), the influence of an approved therapeutic education program (TEP) in patients with joint inflammation requiring a biological treatment initiation.

The hypothesis is that patients attending the TEP will display better cognitive and adaptation competences than patients with no TEP.

Patient's reported quality of life, disease related stress management, treatment adherence, socio-demographic factors, biological home administration modalities and if the biologic treatment is maintained at 12 months, will also be described.

Inclusion Criteria:

• Non-radiological spondyloarthritis diagnosis (ASAS criteria)
• Anti-TNFalpha biological treatment initiation required
• Adult patient (age>18years)
• Capacity to understand self-questionnaires and address questions
• Patient accepting to attend a therapeutic education program (TEP)

Exclusion Criteria:

• Previous Anti-TNFalpha biological treatment
• Previous attendance to a TEP concerning biological or spondyloarthritis
• Contraindication to Anti-TNFalpha treatment
• Associated and unbalanced diseases